
Asprosin may be a useful parameter as a biomarker of periodontal disease progression. However, BMI status should be considered when evaluating asprosin levels in patients with periodontitis.
Authors: Sema Nur Sevinç Gül, Didem Özkal Emi̇noğlu, Esra Laloğlu, Tuğba Aydın, Alparslan Dilsiz
DOI: https://doi.org/10.1007/s00784-024-05494-9
Publish Year: 2024